Zydus gets USFDA approval for surgical imaging drug with 180-day exclusivity window
· thehindubusinessline.com
Zydus receives USFDA approval for a surgical imaging drug, Indocyanine Green, with a 180-day exclusivity window for marketing.
Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) for a specialised injectable drug used by doctors to improve vis...